Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 112


Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey AL, Bastacky S, Dhir R, Parwani AV.

Diagn Pathol. 2015 Sep 29;10(1):179. doi: 10.1186/s13000-015-0412-z.


Splicing factor Prp8 interacts with NESAR and regulates androgen receptor in prostate cancer cells.

Wang D, Nguyen MM, Masoodi KZ, Singh P, Jing Y, O'Malley K, Dhir R, Wang Z.

Mol Endocrinol. 2015 Sep 15:me20151112. [Epub ahead of print]


Data Representation, Coding, and Communication Standards.

Amin M, Dhir R.

Surg Pathol Clin. 2015 Jun;8(2):109-21. doi: 10.1016/j.path.2015.02.001. Review.


Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy.

Amjad AI, Ali H, Appleman LJ, Maranchie J, Jackman S, Parwani A, Dhir R, Roy S, Parikh RA.

Case Rep Oncol Med. 2014;2014:615895. doi: 10.1155/2014/615895. Epub 2014 Aug 19.


Argument for prostate cancer screening in populations of African-Caribbean origin.

Patrick AL, Bunker CH, Nelson JB, Dhir R, Wheeler VW, Zmuda JM, Richard JR, Belle AC, Kuller LH.

BJU Int. 2015 Oct;116(4):507-8. doi: 10.1111/bju.12869. Epub 2015 Jun 11. No abstract available.


Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.

Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A.

Am J Surg Pathol. 2013 Dec;37(12):1824-30. doi: 10.1097/PAS.0000000000000108.


Frozen section diagnosis: is there discordance between what pathologists say and what surgeons hear?

Roy S, Parwani AV, Dhir R, Yousem SA, Kelly SM, Pantanowitz L.

Am J Clin Pathol. 2013 Sep;140(3):363-9. doi: 10.1309/AJCPHUE5ENZDU4DJ.


Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.

Ai J, Pascal LE, O'Malley KJ, Dar JA, Isharwal S, Qiao Z, Ren B, Rigatti LH, Dhir R, Xiao W, Nelson JB, Wang Z.

Oncogene. 2014 May 1;33(18):2286-94. doi: 10.1038/onc.2013.190. Epub 2013 May 27.


Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):518-22. doi: 10.1016/j.canep.2013.03.020. Epub 2013 Apr 23.


Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography.

LaFramboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV, Marroquin OC, Mulukutla SR, McNamara DM.

BMC Med. 2012 Dec 5;10:157. doi: 10.1186/1741-7015-10-157.


Clinical integration of next-generation sequencing technology.

Gullapalli RR, Lyons-Weiler M, Petrosko P, Dhir R, Becich MJ, LaFramboise WA.

Clin Lab Med. 2012 Dec;32(4):585-99. doi: 10.1016/j.cll.2012.07.005. Review.


Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.

Singh SV, Kim SH, Sehrawat A, Arlotti JA, Hahm ER, Sakao K, Beumer JH, Jankowitz RC, Chandra-Kuntal K, Lee J, Powolny AA, Dhir R.

J Natl Cancer Inst. 2012 Aug 22;104(16):1228-39. doi: 10.1093/jnci/djs321. Epub 2012 Aug 2.


Renal cell neoplasms contain shared tumor type-specific copy number variations.

Krill-Burger JM, Lyons MA, Kelly LA, Sciulli CM, Petrosko P, Chandran UR, Kubal MD, Bastacky SI, Parwani AV, Dhir R, LaFramboise WA.

Am J Pathol. 2012 Jun;180(6):2427-39. doi: 10.1016/j.ajpath.2012.01.044. Epub 2012 Apr 3.


Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study.

Rubatt JM, Darcy KM, Tian C, Muggia F, Dhir R, Armstrong DK, Bookman MA, Niedernhofer LJ, Deloia J, Birrer M, Krivak TC.

Gynecol Oncol. 2012 May;125(2):421-6. doi: 10.1016/j.ygyno.2012.01.008. Epub 2012 Jan 16.


Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

Wu Q, Dhir R, Wells A.

Mol Cancer. 2012 Jan 11;11:3. doi: 10.1186/1476-4598-11-3.


Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard.

Zhao T, Zeng X, Bateman NW, Sun M, Teng PN, Bigbee WL, Dhir R, Nelson JB, Conrads TP, Hood BL.

J Proteome Res. 2012 Feb 3;11(2):1089-99. doi: 10.1021/pr200829f. Epub 2011 Dec 1.


Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases.

Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A.

Cancer Microenviron. 2012 Apr;5(1):19-28. doi: 10.1007/s12307-011-0085-4. Epub 2011 Sep 3.


Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.

Visus C, Ito D, Dhir R, Szczepanski MJ, Chang YJ, Latimer JJ, Grant SG, DeLeo AB.

Cancer Immunol Immunother. 2011 Jul;60(7):919-29. doi: 10.1007/s00262-011-1001-y. Epub 2011 Mar 16.


Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate.

Tomaszewski JJ, Cummings JL, Parwani AV, Dhir R, Mason JB, Nelson JB, Bacich DJ, O'Keefe DS.

Prostate. 2011 Sep;71(12):1287-93. doi: 10.1002/pros.21346. Epub 2011 Feb 9.


Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.

Teng PN, Hood BL, Sun M, Dhir R, Conrads TP.

J Proteome Res. 2011 Mar 4;10(3):1333-42. doi: 10.1021/pr101074p. Epub 2011 Jan 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk